Question

What are the limited resources that have created extra demand in the medical field during the times of pandemic?​

plz answer quickley

Answer 1

The limited resources are masks, oxygen cylinders, ventilators, and medical staff.

Explanation:

• Since the pandemic, the demand for medical supplies such as medicines, oxygen, and devices has surged.
• During Covid-19, a public health emergency has risen around the globe.
• There is an acute shortage of masks, oxygen cylinders, ventilators, and medical staff.
• The health care professionals have made heroic efforts to deal with the pandemic but still, there is a collapse in the supply chain management

Answer 2

Limited resources during the pandemic.

The World Health Organization designated “coronavirus disease 2019” (Covid-19) a global pandemic. As the number of cases in the United States continues to grow, political leaders are encouraging physical (or “social”) distancing to slow the rate of transmission. The goal of this practice is to flatten the curve of a new infection, thereby avoiding a surge of demand on the health care system, but the effects of physical distancing may take weeks to appear. U.S. hospitals are already reporting shortages of key equipment needed to care for critically ill patients, including ventilators and personal protective equipment (PPE) for medical staff. Adequate production and distribution of both types of equipment are crucial to caring for patients during the pandemic.

Manufacturers of devices that are critical to public health during a public health emergency, or for which the FDA determines information on potential meaningful supply disruptions is needed during a public health emergency, are required to notify the FDA pursuant to section 506J of the FD&C Act of a permanent discontinuance or interruption in manufacturing of such devices. Manufacturers should review section 506J of the FD&C Act, as well as other parts of the FDA's guidance, Notifying CDRH of a Permanent Discontinuance or Interruption in Manufacturing of a Device under Section 506J of the FD&C Act During the COVID-19 Public Health Emergency (Revised) - Immediately in Effect Guidance for Industry and Food and Drug Administration Staff, to determine whether they are required to notify the FDA under section 506J of the FD&C Act. The information the FDA receives in notifications under Section 506J of the FD&C Act assists the FDA in preventing or mitigating shortages of such devices during the COVID-19 public health emergency, helping to prevent negative impacts to patients and healthcare personnel. Beyond increasing the supply, a crucial role for the government is to coordinate efforts to ensure that the areas hardest hit at any given time are receiving needed equipment. Individual state governments and health care systems are currently competing for resources, and those resources are not necessarily being distributed on the basis of need. Surges of Covid-19 cases are unlikely to happen in all parts of the country at once, so there is an opportunity to coordinate the filling of gaps.